• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用[F]FDG PET/CT对移植后淋巴细胞增生性疾病形态学亚型进行半定量特征分析。

Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [F]FDG PET/CT.

作者信息

Montes de Jesus Felipe, Vergote V, Noordzij W, Dierickx D, Dierckx R A J O, Diepstra A, Tousseyn T, Gheysens O, Kwee T C, Deroose C M, Glaudemans A W J M

机构信息

Department of Nuclear Medicine and Molecular Imaging, University of Groningen, University Medical Center Groningen, 9700 RB Groningen, The Netherlands.

Department of Hematology, University Hospitals Leuven, 3000 Leuven, Belgium.

出版信息

J Clin Med. 2021 Jan 19;10(2):361. doi: 10.3390/jcm10020361.

DOI:10.3390/jcm10020361
PMID:33477971
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7835947/
Abstract

Post-transplant lymphoproliferative disorder (PTLD) is a complication of organ transplantation classified according to the WHO as nondestructive, polymorphic, monomorphic, and classic Hodgkin Lymphoma subtypes. In this retrospective study, we investigated the potential of semi-quantitative 2-[F]fluoro-2-deoxy-D-glucose ([F]FDG) PET/computed tomography (CT)-based parameters to differentiate between the PTLD morphological subtypes. 96 patients with histopathologically confirmed PTLD and baseline [F]FDG PET/CT between 2009 and 2019 were included. Extracted semi-quantitative measurements included: Maximum, peak, and mean standardized uptake value (SUV, SUV, and SUV). Median SUVs were highest for monomorphic PTLD followed by polymorphic and nondestructive subtypes. The median SUV at the biopsy site was significantly higher in monomorphic PTLD (17.8, interquartile range (IQR):16) than in polymorphic subtypes (9.8, IQR:13.4) and nondestructive (4.1, IQR:6.1) ( = 0.04 and ≤ 0.01, respectively). An SUV ≥ 24.8 was always indicative of a monomorphic PTLD in our dataset. Nevertheless, there was a considerable overlap in SUV across the different morphologies. The median SUV at the biopsy site was significantly higher in monomorphic PTLD than polymorphic and nondestructive subtypes. However, due to significant SUV overlap across the different subtypes, these values may only serve as an indication of PTLD morphology, and SUV-based parameters cannot replace histopathological classification.

摘要

移植后淋巴细胞增生性疾病(PTLD)是器官移植的一种并发症,根据世界卫生组织的分类,可分为非破坏性、多形性、单形性和经典霍奇金淋巴瘤亚型。在这项回顾性研究中,我们调查了基于半定量2-[F]氟-2-脱氧-D-葡萄糖([F]FDG)PET/计算机断层扫描(CT)的参数区分PTLD形态学亚型的潜力。纳入了96例在2009年至2019年间经组织病理学确诊为PTLD且有基线[F]FDG PET/CT的患者。提取的半定量测量值包括:最大、峰值和平均标准化摄取值(SUVmax、SUVpeak和SUVmean)。单形性PTLD的SUV中位数最高,其次是多形性和非破坏性亚型。单形性PTLD活检部位的SUV中位数(17.8,四分位间距(IQR):16)显著高于多形性亚型(9.8,IQR:13.4)和非破坏性亚型(4.1,IQR:6.1)(分别为P = 0.04和P≤0.01)。在我们的数据集中,SUV≥24.8总是提示单形性PTLD。然而,不同形态的SUV存在相当大的重叠。单形性PTLD活检部位的SUV中位数显著高于多形性和非破坏性亚型。然而,由于不同亚型之间SUV存在显著重叠,这些值可能仅作为PTLD形态的一个指标,基于SUV的参数不能替代组织病理学分类。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/0e8322fb8236/jcm-10-00361-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/775e97090e92/jcm-10-00361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/f406ad16fa34/jcm-10-00361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/bbb7fb0a9238/jcm-10-00361-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/0e8322fb8236/jcm-10-00361-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/775e97090e92/jcm-10-00361-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/f406ad16fa34/jcm-10-00361-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/bbb7fb0a9238/jcm-10-00361-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/73fb/7835947/0e8322fb8236/jcm-10-00361-g004.jpg

相似文献

1
Semi-Quantitative Characterization of Post-Transplant Lymphoproliferative Disorder Morphological Subtypes with [F]FDG PET/CT.利用[F]FDG PET/CT对移植后淋巴细胞增生性疾病形态学亚型进行半定量特征分析。
J Clin Med. 2021 Jan 19;10(2):361. doi: 10.3390/jcm10020361.
2
The value of F-FDG PET/CT quantitative indexes in the diagnosis of nondestructive posttransplant lymphoproliferative disorders after pediatric liver transplantation.~ F-FDG PET/CT 定量指标在儿童肝移植后非侵袭性移植后淋巴组织增生性疾病诊断中的价值。~
Pediatr Transplant. 2023 Aug;27(5):e14501. doi: 10.1111/petr.14501. Epub 2023 Mar 11.
3
F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders.氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在儿科移植后淋巴增殖性疾病的诊断和治疗评估中的应用。
J Nucl Med. 2020 Sep;61(9):1307-1313. doi: 10.2967/jnumed.119.239624. Epub 2020 Jan 31.
4
Diagnostic and management roles of FDG PET/CT imaging in post-transplant lympho-proliferation in pediatric heart transplantation.移植后心脏儿童心脏移植后淋巴组织增生症的 FDG PET/CT 成像的诊断和治疗作用。
Clin Transplant. 2023 Sep;37(9):e15015. doi: 10.1111/ctr.15015. Epub 2023 May 26.
5
The role of F-FDG PET/CT metabolic parameters in the differential diagnosis of post-transplant lymphoproliferative disorder after pediatric liver transplantation.F-FDG PET/CT代谢参数在儿童肝移植术后移植后淋巴组织增生性疾病鉴别诊断中的作用
Quant Imaging Med Surg. 2024 Feb 1;14(2):1323-1334. doi: 10.21037/qims-23-1059. Epub 2024 Jan 5.
6
(18)F-FDG PET/CT in the management of patients with post-transplant lymphoproliferative disorder.(18)氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在移植后淋巴增殖性疾病患者管理中的应用
Nucl Med Commun. 2014 Mar;35(3):276-81. doi: 10.1097/MNM.0000000000000050.
7
The value of 18F-FDG PET in pediatric patients with post-transplant lymphoproliferative disorder at initial diagnosis.18F-FDG PET在移植后淋巴细胞增生性疾病初诊儿科患者中的价值。
Pediatr Transplant. 2015 Dec;19(8):932-9. doi: 10.1111/petr.12611. Epub 2015 Oct 30.
8
Image findings of monomorphic non-hogdkin lymphoproliferative disorder in a post renal transplant patient diagnosed with fluorine-18 fluorodeoxyglucose-positron emission tomography/computed tomography.一名肾移植术后患者经氟-18氟脱氧葡萄糖正电子发射断层扫描/计算机断层扫描诊断为单形性非霍奇金淋巴瘤增殖性疾病的影像表现
Indian J Nucl Med. 2014 Jul;29(3):189-90. doi: 10.4103/0972-3919.136596.
9
F-FDG PET/CT findings in a patient with blastic plasmacytoid dendritic cell neoplasm and post-transplant lymphoproliferative disorder after hematopoietic stem cell transplantation: a case report.18F-氟代脱氧葡萄糖正电子发射断层显像/计算机断层扫描在1例浆细胞样树突状细胞肿瘤和造血干细胞移植后移植后淋巴增殖性疾病患者中的表现:病例报告
Front Med (Lausanne). 2023 Aug 17;10:1258310. doi: 10.3389/fmed.2023.1258310. eCollection 2023.
10
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.移植后淋巴组织增生性疾病的 FDG-PET/CT 诊断性能及影响诊断产量的因素。
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):529-536. doi: 10.1007/s00259-019-04481-7. Epub 2019 Aug 24.

引用本文的文献

1
F-FDG PET/CT imaging of posttransplant lymphoproliferative disorder following renal transplantation: Three clinical cases.肾移植后移植后淋巴增殖性疾病的F-FDG PET/CT成像:三例临床病例
Heliyon. 2023 Mar 22;9(4):e14746. doi: 10.1016/j.heliyon.2023.e14746. eCollection 2023 Apr.
2
The Role of Pre-therapeutic F-FDG PET/CT in Pediatric Hemophagocytic Lymphohistiocytosis With Epstein-Barr Virus Infection.治疗前F-FDG PET/CT在小儿爱泼斯坦-巴尔病毒感染相关噬血细胞性淋巴组织细胞增生症中的作用
Front Med (Lausanne). 2022 Jan 21;8:836438. doi: 10.3389/fmed.2021.836438. eCollection 2021.

本文引用的文献

1
Identification of high-risk monomorphic post-transplant lymphoproliferative disorder following solid organ transplantation.实体器官移植后高危单形性移植后淋巴组织增生性疾病的鉴定。
Leuk Lymphoma. 2021 Jan;62(1):86-94. doi: 10.1080/10428194.2020.1821006. Epub 2020 Sep 16.
2
Diagnostic Performance of F-FDG PET or PET/CT for Detection of Post-Transplant Lymphoproliferative Disorder: A Systematic Review and a Bivariate Meta-Analysis.F-FDG PET或PET/CT检测移植后淋巴增殖性疾病的诊断性能:一项系统评价和双变量Meta分析
Diagnostics (Basel). 2020 Feb 12;10(2):101. doi: 10.3390/diagnostics10020101.
3
F-FDG PET/CT in the Diagnostic and Treatment Evaluation of Pediatric Posttransplant Lymphoproliferative Disorders.
氟代脱氧葡萄糖正电子发射断层扫描/计算机断层扫描在儿科移植后淋巴增殖性疾病的诊断和治疗评估中的应用。
J Nucl Med. 2020 Sep;61(9):1307-1313. doi: 10.2967/jnumed.119.239624. Epub 2020 Jan 31.
4
Diagnostic performance of FDG-PET/CT of post-transplant lymphoproliferative disorder and factors affecting diagnostic yield.移植后淋巴组织增生性疾病的 FDG-PET/CT 诊断性能及影响诊断产量的因素。
Eur J Nucl Med Mol Imaging. 2020 Mar;47(3):529-536. doi: 10.1007/s00259-019-04481-7. Epub 2019 Aug 24.
5
Metagenomic analysis of DNA viruses from posttransplant lymphoproliferative disorders.移植后淋巴组织增生性疾病中 DNA 病毒的宏基因组分析。
Cancer Med. 2019 Mar;8(3):1013-1023. doi: 10.1002/cam4.1985. Epub 2019 Jan 29.
6
The Tumor Microenvironment in Post-Transplant Lymphoproliferative Disorders.移植后淋巴增殖性疾病中的肿瘤微环境
Cancer Microenviron. 2019 Apr;12(1):3-16. doi: 10.1007/s12307-018-00219-5. Epub 2019 Jan 24.
7
Prognostic value of baseline metabolic tumor volume and total lesion glycolysis in patients with lymphoma: A meta-analysis.基线代谢肿瘤体积和总病变糖酵解对淋巴瘤患者的预后价值:一项荟萃分析。
PLoS One. 2019 Jan 9;14(1):e0210224. doi: 10.1371/journal.pone.0210224. eCollection 2019.
8
Performance of advanced imaging modalities at diagnosis and treatment response evaluation of patients with post-transplant lymphoproliferative disorder: A systematic review and meta-analysis.移植后淋巴组织增生性疾病患者的诊断和治疗反应评估中高级影像学方法的性能:系统评价和荟萃分析。
Crit Rev Oncol Hematol. 2018 Dec;132:27-38. doi: 10.1016/j.critrevonc.2018.09.007. Epub 2018 Sep 19.
9
EANM/EARL FDG-PET/CT accreditation - summary results from the first 200 accredited imaging systems.EANM/EARL FDG-PET/CT 认证 - 首批 200 个已认证成像系统的总结结果。
Eur J Nucl Med Mol Imaging. 2018 Mar;45(3):412-422. doi: 10.1007/s00259-017-3853-7. Epub 2017 Dec 1.
10
Real-time intraprocedural F-FDG PET/CT-guided biopsy using automated robopsy arm (ARA) in the diagnostic evaluation of thoracic lesions with prior inconclusive biopsy results: initial experience from a tertiary health care centre.在先前活检结果不确定的胸部病变诊断评估中,使用自动活检臂(ARA)进行实时术中F-FDG PET/CT引导活检:来自三级医疗中心的初步经验。
Br J Radiol. 2017 Dec;90(1080):20170258. doi: 10.1259/bjr.20170258. Epub 2017 Oct 27.